ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition.

[1]  G. Molenberghs,et al.  Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials. , 2023, JAMA.

[2]  Kunlun Huang,et al.  Alkalihalobacillus clausii PA21 transcriptome profiling and functional analysis revealed the metabolic pathway involved in glycoalkaloids degradation. , 2023, International journal of biological macromolecules.

[3]  V. Aidinis,et al.  The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer , 2023, International journal of molecular sciences.

[4]  V. Salomaa,et al.  Gut microbiome and atrial fibrillation—results from a large population-based study , 2023, EBioMedicine.

[5]  E. Kuipers,et al.  Young-onset colorectal cancer , 2023, Nature Reviews Disease Primers.

[6]  M. Lai,et al.  Elevated serum β-hydroxybutyrate, a circulating ketone metabolite, accelerates colorectal cancer proliferation and metastasis via ACAT1 , 2023, Oncogene.

[7]  X. Miao,et al.  Saturated fatty acid intake, genetic risk and colorectal cancer incidence: A large‐scale prospective cohort study , 2023, International journal of cancer.

[8]  Y. Zong,et al.  Cytokine concentration in peripheral blood of patients with colorectal cancer , 2023, Frontiers in Immunology.

[9]  P. Jay,et al.  Intestinal tuft cells: Sentinels, what else? , 2023, Seminars in cell & developmental biology.

[10]  Qiang Yu,et al.  Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant , 2023, Signal Transduction and Targeted Therapy.

[11]  A. Cuadrado,et al.  Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets , 2023, Redox biology.

[12]  S. Yachida,et al.  Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer , 2022, International journal of cancer.

[13]  V. Aidinis,et al.  Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications , 2022, Cancers.

[14]  Xingxu Huang,et al.  Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR‐Mediated Base Editors , 2022, Advanced science.

[15]  R. Andrade,et al.  Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury. , 2022, Pharmacological research.

[16]  Daeui Park,et al.  Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4/6 Inhibitor Through Regulation of PD-L1 , 2022, Cellular and molecular gastroenterology and hepatology.

[17]  V. Aidinis,et al.  Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice , 2022, Arteriosclerosis, thrombosis, and vascular biology.

[18]  F. Gao,et al.  Gut Microbiota Combined with Metabolites Reveals Unique Features of Acute Myocardial Infarction Patients Different from Stable Coronary Artery Disease. , 2022, Journal of advanced research.

[19]  A. Perrakis,et al.  Autotaxin facilitates selective LPA receptor signaling , 2022, bioRxiv.

[20]  Xiaohui Xie,et al.  Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening , 2022, Oncogene.

[21]  Jian Wang,et al.  HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment , 2022, Theranostics.

[22]  Haitao Zhao,et al.  Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers , 2021, Journal for ImmunoTherapy of Cancer.

[23]  Lori A. Coburn,et al.  CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis , 2021, Oncogene.

[24]  X. Zhai,et al.  Structural and PK-guided identification of indole-based non-acidic autotaxin (ATX) inhibitors exhibiting high in vivo anti-fibrosis efficacy in rodent model. , 2021, European journal of medicinal chemistry.

[25]  M. Wuest,et al.  Positron Emission Tomography Imaging of Autotaxin in Thyroid and Breast Cancer Models Using [18F]PRIMATX. , 2021, Molecular pharmaceutics.

[26]  M. Cooperberg,et al.  Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes , 2021, International journal of molecular sciences.

[27]  Xiaotian Zhang,et al.  The Expression Regulation and Biological Function of Autotaxin , 2021, Cells.

[28]  Fei Zhang,et al.  Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma , 2021, OncoTargets and therapy.

[29]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[30]  Xinxiang Li,et al.  Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer , 2020, Journal of Hematology & Oncology.

[31]  H. Yu,et al.  Autotaxin stimulates LPA2 receptor in macrophages and exacerbates dextran sulfate sodium-induced acute colitis , 2020, Journal of Molecular Medicine.

[32]  P. Hruz,et al.  Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis. , 2020, Cell reports.

[33]  Jun Yu,et al.  High-Fat Diet Promotes Colorectal Tumorigenesis through Modulating Gut Microbiota and Metabolites. , 2020, Gastroenterology.

[34]  T. Schumacher,et al.  Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells , 2020, bioRxiv.

[35]  Di Chen,et al.  A SNP of bacterial blc disturbs gut lysophospholipid homeostasis and induces inflammation through epithelial barrier disruption , 2020, EBioMedicine.

[36]  Jun Sun,et al.  Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. , 2020, Gastroenterology.

[37]  H. Fan,et al.  Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice , 2019, Inflammation.

[38]  Lian‐Wen Qi,et al.  Tyrosine and Glutamine-Leucine Are Metabolic Markers of Early-Stage Colorectal Cancers. , 2019, Gastroenterology.

[39]  Tomoyoshi Soga,et al.  Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer , 2019, Nature Medicine.

[40]  Andrew R. Bassett,et al.  GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump , 2019, Science Signaling.

[41]  R. Pfeiffer,et al.  Circulating inflammatory markers and colorectal cancer risk: A prospective case‐cohort study in Japan , 2018, International journal of cancer.

[42]  Jun Yu,et al.  The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get , 2018, Protein & Cell.

[43]  R. Parenti,et al.  The phospholipase DDHD1 as a new target in colorectal cancer therapy , 2018, Journal of experimental & clinical cancer research : CR.

[44]  Zhenwei Dai,et al.  Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers , 2018, Microbiome.

[45]  Honglin Li,et al.  Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases , 2017, Circulation.

[46]  G. Nolan,et al.  A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites , 2017, Nature.

[47]  Joon Yoon,et al.  Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet , 2017, PloS one.

[48]  Patrick D Schloss,et al.  Structure of the gut microbiome following colonization with human feces determines colonic tumor burden , 2014, Microbiome.